N-β-Diethylaminoethyl-harnstoff | 54743-31-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-β-Diethylaminoethyl-harnstoff
• 英文别名: (2-diethylamino-ethyl)-urea；(2-Diaethylamino-aethyl)-harnstoff；2-(Diethylamino)ethylurea
• CAS: 54743-31-6
• 化学式: C₇H₁₇N₃O
• 分子量: 159.231
• InChiKey: OYULQAZWUYPDMQ-UHFFFAOYSA-N

物化性质

• 熔点：
  137-140 °C(Solv: ethanol (64-17-5))
• 沸点：
  239.0±32.0 °C(Predicted)
• 密度：
  0.989±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  58.4
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-β-Diethylaminoethyl-harnstoff 210.0 ℃ 、4.0 kPa 条件下， 生成 N,N'-bis-(2-diethylamino-ethyl)-urea
  参考文献：
  名称：

  Chiti; Selleri, Farmaco, Edizione Scientifica, 1956, vol. 11, p. 607,613

  摘要：

  DOI：
• 作为产物：
  描述：

  N,N-二乙基乙二胺 在 氢氧化钾 作用下， 生成 N-β-Diethylaminoethyl-harnstoff
  参考文献：
  名称：

  Casagrande; Galli; Ferrini, Farmaco, Edizione Scientifica, 1974, vol. 29, # 10, p. 757 - 785

  摘要：

  DOI：

文献信息

• N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0228845A2

  公开（公告）日：1987-07-15

  An N-containing heterocyclic compound of the formula: I wherein R' is lower alkyl optionally substituted with hydroxy, halogen or a heterocyciic group, carboxy, esterified carboxy, carbamoyl optionally substituted with heterocyclic(lower)alkyl or lower alkylamino(lower)alkyl, N-containing heterocycliccarbonyl optionally substituted with lower alkyl, or ureido optionally substituted with lower alkylamino(lower)alkyl, and R3 is hydrogen or halogen; R2 is phenyl substituted with nitro, and X is = N-or in which R' is lower alkyl or halo (lower) alkyl, or is taken together with R' to form an N-containing heterocyclic group optionally substituted with oxo and lower alkylamino(lower)alkyl; or R2 is lower alkyl, and X is in which R4 is phenyl substituted with nitro; and a pharmaceutically acceptable salt thereof, processes for the preparation thereof and composition comprising the same.

  式中的含 N 杂环化合物：I 其中 R'是任选被羟基、卤素或杂环基取代的低级烷基、羧基、酯化羧基、任选被杂环（低级）烷基或低级烷基氨基（低级）烷基取代的氨基甲酰基、任选被低级烷基取代的含 N 杂环羰基或任选被低级烷基氨基（低级）烷基取代的脲基，以及 R3 是氢或卤素； R2 是被硝基取代的苯基，以及 X 是 = N-or 其中 R'是低级烷基或卤代（低级）烷基，或与 R'一起形成可选被氧代和低级烷基氨基（低级）烷基取代的含 N 杂环基团；或 R2 是低级烷基，且 X 是 其中 R4 是被硝基取代的苯基； 及其药学上可接受的盐、制备工艺和包含这些成分的组合物。
• Pyridine or pyridazine derivatives as cardio-protective agents and for the treatment of ischemic disease, and process for their preparation
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0311322A2

  公开（公告）日：1989-04-12

  A pharmaceutical composition as a cardioprotective agent or as a therapeutic agent for ischemic disease comprising a compound of the formula: wherein R1 is lower alkyl substituted with a heterocyclic group; carbamoyl substituted with heterocyclic(lower)alkyl or with lower alkylamino(lower)alkyl; N-containing heterocycliccarbonyl optionally substituted with lower alkyl; or ureido substituted with lower alkylamino(lower)alkyl; and R2 is phenyl substituted with nitro, and in which R3 is lower alkyl; or R2 is lower alkyl, and in which R3 is phenyl substituted with nitro; or its salt, as an active ingredient, in association with a pharmaceutically acceptable, substantially nontoxic carrier or excipient, and a process for the preparation of some of said compound or their salts

  一种作为心脏保护剂或缺血性疾病治疗剂的药物组合物，包含一种式化合物： 式中 R1 是被杂环基取代的低级烷基；被杂环（低级）烷基或低级烷基氨基（低级）烷基取代的氨基甲酰基；任选被低级烷基取代的含 N 杂环羰基；或被低级烷基氨基（低级）烷基取代的脲基；和 R2 是被硝基取代的苯基，以及 其中 R3 是低级烷基；或 R2 是低级烷基，且 其中 R3 是被硝基取代的苯基；或其盐，作为活性成分，与药学上可接受的、实质上无毒的载体或赋形剂一起使用，以及制备某些上述化合物或其盐的方法
• Chiti; Selleri, Farmaco, Edizione Scientifica, 1958, vol. 13, p. 261,282
  作者：Chiti、Selleri

  DOI：——

  日期：——
• CHITI, Farmaco, Edizione Scientifica, 1960, vol. 15, p. 29 - 43
  作者：CHITI

  DOI：——

  日期：——
• Chiti; Sellerie, Farmaco, Edizione Scientifica, 1958, vol. 13, p. 590,600
  作者：Chiti、Sellerie

  DOI：——

  日期：——